Birmingham, West Midlands -- (SBWIRE) -- 12/20/2013 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: JetBlue Airways Corporation (NASDAQ:JBLU), Hovnanian Enterprises, Inc (NYSE:HOV), BG Medicine, Inc (NASDAQ:BGMD), United Microelectronics Corp (ADR) (NYSE:UMC)
JetBlue Airways Corporation (NASDAQ:JBLU) the stock opened the session at $8.52 but then moved to $8.47. At that price, the stock showed a negative performance of 0.94%. JetBlue Airways Corporation (JetBlue) is a passenger airline that operates primarily on point-to-point routes with its fleet of 120 Airbus A320 aircraft and 49 EMBRAER 190 aircraft. As of December 31, 2011, it served 70 destinations in 22 states, Puerto Rico, Mexico and 12 countries in the Caribbean and Latin America. Most of JetBlue flights have as an origin or destination New York or one of its other focus cities: Boston, Fort Lauderdale,
Will JBLU Get Buyers Even After The Recent Rally? Find Out Here
Hovnanian Enterprises, Inc (NYSE:HOV) opened the session at $5.67 and closed the session at $5.64. The stock showed a negative performance of -1.23% in previous trading session. Hovnanian Enterprises, Inc. (Hovnanian) designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, mid-rise condominiums, urban infill and active adult homes in planned residential developments. The Company consists of two distinct operations: homebuilding and financial services.
Has HOV Found The Bottom And Ready To Gain Momentum? Find Out Here
BG Medicine, Inc (NASDAQ:BGMD) opened the session at $1.07 and closed the session at $1.01. The stock showed a negative performance of -2.88% in previous trading session. BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque.
Why Should Investors Buy BGMD After the Recent Fall? Just Go Here and Find Out
United Microelectronics Corp (ADR) (NYSE:UMC) the stock decreased -0.50% and finished the session at $1.98. Traded with volume of 2.91 million shares in the prior session and the average volume of the stock remained 954,489.00 shares. The beta of the stock remained 1.60. United Microelectronics Corp. is principally engaged in the manufacturing of semiconductor products. The Company operates its businesses primarily through wafer production services. The Company provides the customer-tailored design, testing and production of silicon intellectual property (IP) products, embedded integrated circuits (ICs),
Will UMC Get Buyers Even After The Recent Rally? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)